SARACINO, ANNALISA
 Distribuzione geografica
Continente #
NA - Nord America 2.202
EU - Europa 1.661
AS - Asia 831
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 3
AF - Africa 1
OC - Oceania 1
Totale 4.704
Nazione #
US - Stati Uniti d'America 2.200
CN - Cina 634
IE - Irlanda 579
UA - Ucraina 456
SE - Svezia 339
SG - Singapore 106
FI - Finlandia 80
GB - Regno Unito 72
TR - Turchia 68
DE - Germania 43
FR - Francia 27
BE - Belgio 23
IT - Italia 23
IN - India 20
RU - Federazione Russa 9
EU - Europa 5
CZ - Repubblica Ceca 4
AL - Albania 2
AR - Argentina 2
CA - Canada 2
AM - Armenia 1
AT - Austria 1
HK - Hong Kong 1
KG - Kirghizistan 1
MA - Marocco 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
PT - Portogallo 1
PY - Paraguay 1
Totale 4.704
Città #
Dublin 576
Chandler 481
Jacksonville 326
Dearborn 252
Nyköping 212
Nanjing 158
Ann Arbor 86
Wilmington 81
Beijing 68
Singapore 68
Woodbridge 67
Ashburn 66
Princeton 66
San Mateo 66
Nanchang 60
Boardman 47
Shenyang 45
Kunming 30
Tianjin 27
Hebei 26
Los Angeles 24
Brussels 21
Changsha 20
Jiaxing 20
Hangzhou 17
Des Moines 16
Guangzhou 15
Helsinki 15
Shanghai 15
Munich 13
New York 12
Ningbo 12
Jinan 10
London 10
Lanzhou 9
Norwalk 9
Zhengzhou 9
Washington 7
Auburn Hills 6
Changchun 6
Chicago 6
Haikou 5
Hanover 5
Hefei 5
Stevenage 5
Taizhou 5
Pune 4
Wuhan 4
Florence 3
Palermo 3
Philadelphia 3
Saint Petersburg 3
Brescia 2
Brno 2
Gunzenhausen 2
Hilden 2
Leawood 2
Olomouc 2
Romainville 2
Salerno 2
Salt Lake City 2
Seattle 2
Toronto 2
Wuyuan 2
Zibo 2
Augusta 1
Baotou 1
Bishkek 1
Bitonto 1
Buenos Aires 1
Buffalo 1
Central 1
Dalian 1
Federal 1
Fuzhou 1
Geislingen an der Steige 1
Jinhua 1
Lambaré 1
Layton 1
Lisbon 1
Longyan 1
Lower Hutt 1
Milan 1
Orange 1
Oslo 1
Putignano 1
Quanzhou 1
Rabat 1
Redmond 1
Rui'an 1
Vienna 1
Warsaw 1
Wuxi 1
Xuzhou 1
Yerevan 1
Zhenjiang 1
Totale 3.182
Nome #
Il trattamento dell’infezione da HIV nei Paesi Poveri. 100
Frequent cervicovaginal shedding of HIV-1 in asymptomatic, non-severly immunodeficient women 95
Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretrovirals therapies 91
Frequent detection of HIV-RNA but low rates of HIV-1 isolation in cervico-vaginal secretions from infected women 90
Prevalence of HBV-genotypes in immigrants affected by HBV-related chronic active hepatitis 90
Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors 89
Cervicovaginal HIV-1 shedding in pregnant women near delivery 89
Reproductive choice in individuals HIV-1 infected in South Eastern Italy 88
Epidemiologic multicenter study of the prevalence of hepatitis in hospitalised immigrants in Italy in the year 2002 88
Detection of human herpesvirus 8 in cervicovaginal secretions and seroprevalence in human immunodeficiency virus type 1-seropositive and –seronegative women 84
Efficacy and tolerability of lamivudine alone versus lamivudine plus alpha-interferon for treatment of chronic active hepatitis B in patients with a precore-mutant variant 81
Evidence for a local synthesis of beta-chemokines within the genital tract of both HIV-1 infected and uninfected women 81
Linfoadenopatie 81
V3 sequences and paired HIV isolates from 52 non-subtype B HIV type 1-infected patients 81
Association between HLA class II antigens and hepatitis C virus infection 80
Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART 79
Epidemiological multicentric Italian society of infectious and tropical diseases study on prevalence of tropical diseases in hospitalized immigrants in Italy during 2002 78
Multiple recurrences of vertebral hydatidosis: a case report 77
Clinical and virological response to adefovir dipovixil for lamivudine-resistant HBeAg-negative hepatitis B 77
Drug Resistance Mutations and Newly Recognized Treatment-Related Substitutions in the HIV-1 Protease Gene: Prevalence and Associations With Drug Exposure and Real or Virtual Phenotypic Resistance to Protease Inhibitors in Two Clinical Cohorts of Antiretroviral Experienced Patients 77
Peginterferon alfa-2b Treatment for Patients Affected by Acute Hepatitis C: Presentation of Six Case Reports 77
X4 viruses are frequently archived in patients with long-term HIV infection but do not seem to influence the "inflamm-aging" process. 76
Treatment of genotype 1b HCV-related chronic hepatitis: efficacy and toxicity of three different interferon alfa-2b/ribavirin combined regimens in naive patients 75
Limited secretory IgA response in cervicovaginal secretions from HIV-1 infected, but not high risk seronegative women: lack of correlation to genital viral shedding” 75
Mutational patterns of paired blood and rectal biopsies in HIV-infected patients on HAART 75
Epidemiology of tuberculosis in immigrant patients hospitalised in Infectious Disease Units in Italy: multicentric study 75
Early and sustained virological response in non-responders with chronic hepatitis C: a randomized open-label study of pegylated interferon-alpha-2a versus pegylated interferon-alpha-2b 74
Difficulties in classifying a/g recombinants: methodological problems or genetic variability? 73
Prevalence of HIV infections in hospitalised immigrants in Clinics of Infectious Diseases in Italy: a multicentric survey 72
Mixed cryoglobulinemia in HCV mono-infected and HCV/HIV co-infected patients 72
Intrabiliary rupture of a hydatid liver cyst: a case report 71
HIV-1 phenotypic susceptibility to Lopinavir (LPV) and Genotypic analysis in LPV/r naïve subjects with prior PI experience 71
Are the proposed env mutations actually associated with resistance to maraviroc? 71
Prolonged lamivudine treatment in patients with chronic active anti-HBe-positive hepatitis 70
Peg-interferon alpha-2a versus Peg-interferon alpha-2b in non-responders with HCV active chronic hepatitis: a pilot study 68
Autochtonous mucosal leishmaniasis in a hemodialyzed italian patient 68
Clinical validation and applicability of different tipranavir/ritonavir genotypic scores in HIV-1 protease inhibitor-experienced patients 68
Both a protective and a deleterious role for the L76V mutation 68
"In vitro" spontaneous production of B-chemokines by endocervical and endometrial short-term bioptic cultures 68
HIV-1 resistance to dideoxynucleoside reverse transcriptase inhibitors: genotypic-phenotypic correlations 67
Simit epidemiological multicentric study on hospitalized immigrants in Italy during 2002 67
Selection of antiretroviral therapy guided by genotypic or phenotypic resistance testing: an open-label, randomized, multicenter study (PhenGen) 66
Genotypic resistance to tipranavir/ritonavir (TPV/r) in the Italian EAP BI 1182.16 study 66
Genotypic analysis of the protease and reverse transcriptase of non-B HIV type 1 clinical isolates from naives and treated patients 65
Co-receptor switch during HAART is independent of virological success 65
Extended lamivudine treatment in patients affected by chronic active anti-Hbe positive hepatitis 64
Low prevalence of HIV infection among immigrants within two months of their arrival in Italy 64
HIV-1 RNA detection in cervico-vaginal secretions from HIV-1 seropositive women: clinical and immunological correlates 64
HIV-1 disease progression in women: role of viral phenotype of the HIV-positive steady partner 62
Terapia dell’infezione da HIV 62
Gastrointestinal infection due to anisakis simplex in Southern Italy 60
HIV-1 subtypes and circulating recombinant forms (CRFs) from HIV-infected patients residing in two regions of central and southern Italy 60
A Multidrug-Resistant (MDR) HIV Type 1 Infection in a Homosexual Man and Identified Source Patient 60
HIV infection and protease genetic diversity in a rural area of the Southern Central African Republic 58
Fatal persistent hyponatriemia in an AIDS patient 56
Improved virological outcome in non-B patients: A possible role for baseline coreceptor tropism 56
Immigration and hepatitis B virus: epidemiological, clinical and therapeutic aspects 52
An outbreak of HIV-1 BC recombinants in Southern Italy 52
Genotypic resistance to Tipranavir/Ritonavir (TPV/R): correlation with a -1log HIV-RNA decline at 12 and 24 weekks in PI-experienced patients enrolled in the Italian Expanded Acces for Tipranavir 52
Hepatitis B and immigrants: a SIMIT multicenter cross-sectional study. 52
QTc interval prolongation and life-threatening arrhythmias during hospitalization in patients with COVID-19. Results from a multi-center prospective registry 52
Reproductive choice in individuals HIV-1 infected in South Eastern Italy 51
Rapid and persistent selection of the K103N mutation as a majority quasispecies in a HIV1-patient exposed to efavirenz for three weeks: A case report and review of the literature 42
Impact of mutations outside the V3 region on coreceptor tropism phenotypically assessed in patients infected with HIV-1 subtype B 40
Limph node tuberculosis in immigrant adult patients: retrospective evaluation of four cases 40
HIV-1 nonsubtype B distribution across certain resource-rich countries 38
Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study) 26
Monkeypox Virus Infections in Southern Italy: Is There a Risk for Community Spread? 20
High risk of unsuccessful treatment outcome in migrant population with tuberculosis: Data from three Italian hospitals 19
PrEP in Italy: The time may be ripe but who's paying the bill? A nationwide survey on physicians' attitudes towards using antiretrovirals to prevent HIV infection 17
A Step Closer to the "Fourth 90": A Practical Narrative Review of Diagnosis and Management of Nutritional Issues of People Living with HIV 15
General Practitioners as partners for a shared management of chronic HIV infection: An insight into the perspectives of Italian People Living with HIV 13
Decrease in Incidence Rate of Hospitalizations Due to AIDS-Defining Conditions but Not to Non-AIDS Conditions in PLWHIV on cART in 2008-2018 in Italy 11
Virological response and retention in care according to time of starting ART in Italy: data from the Icona Foundation Study cohort 8
Impact of Innate Immunity, Endothelial Damage, and Metabolic Biomarkers on COVID-19 Severity and Mortality 8
Perturbations of the T-cell receptor repertoire in response to SARS-CoV-2 in immunocompetent and immunocompromised individuals 8
What Is the Efficacy of Sotrovimab in Reducing Disease Progression and Death in People with COVID-19 during the Omicron Era? Answers from a Real-Life Study 7
Knowledge, attitudes, and practices about HIV and other sexually transmitted infections among High School students in Southern Italy: A cross-sectional survey 6
Low-Wage Agricultural Migrant Workers in Apulian Ghettos, Italy: General Health Conditions Assessment and HIV Screening 6
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study 5
Is HCV elimination among persons living with HIV feasible? Data from the NoCo study in the setting of the ICONA cohort 5
Increased risk of virological failure to the first antiretroviral regimen in HIV‐infected migrants compared to natives: data from the ICONA cohort 5
Assessing ChatGPT's Potential in HIV Prevention Communication: A Comprehensive Evaluation of Accuracy, Completeness, and Inclusivity 5
The impact of DAA‐mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 5
Totale 4.785
Categoria #
all - tutte 24.275
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.275


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020623 0 0 0 0 117 135 160 10 95 7 83 16
2020/2021506 69 0 73 1 65 60 76 8 68 81 3 2
2021/2022347 72 0 0 8 7 6 15 29 55 50 11 94
2022/20231.702 151 86 53 153 104 177 5 129 690 49 41 64
2023/2024317 68 10 21 11 32 67 13 15 10 8 1 61
2024/2025199 47 27 33 42 50 0 0 0 0 0 0 0
Totale 4.785